Related Experiment Video
Updated: Aug 26, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
Altered Rho GTPase signaling pathways in breast cancer cells
Peter Burbelo1, Anton Wellstein, Richard G Pestell
1Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA.
Abstract:
The Rho family of GTPases have emerged as key players in regulating a diverse set of biological activities including actin organization, focal complex/adhesion assembly, cell motility, cell polarity, gene transcription and cell-cycle progression. Some Rho GTPases and their signaling components are overexpressed and/or are hyperactive in breast cancer and recent studies have shown a requirement for Rho GTPases in breast cancer cell metastasis in vivo. Herein we describe the contribution of Rho GTPase to the malignant phenotype of breast cancer cells and the role of these pathways as potential targets for breast cancer therapy. Rho GTPases promote cell-cycle progression through cyclin D1, and cyclin D1 in turn reduces cellular adhesion and promotes migration, an example of 'inside-out' signaling by cyclin D1. As cyclin D1 overexpression correlates with metastatic cancer, the 'inside-out' signaling function of cyclin D1 to promote cell migration may represent a useful new therapeutic target.
Insights
Rho GTPases are crucial for breast cancer cell metastasis. Targeting Rho GTPase pathways, particularly cyclin D1
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Rho GTPases regulate fundamental cellular processes like actin organization, motility, and cell-cycle progression.
- Aberrant Rho GTPase activity is implicated in breast cancer progression and metastasis.
Purpose of the Study:
- To elucidate the role of Rho GTPases in the malignant phenotype of breast cancer.
- To explore Rho GTPase pathways as potential therapeutic targets for breast cancer.
Main Methods:
- The study focuses on the signaling mechanisms involving Rho GTPases and cyclin D1.
- Analysis of Rho GTPase contribution to breast cancer cell characteristics.
Main Results:
- Rho GTPases promote cell-cycle progression via cyclin D1.
- Cyclin D1 mediates 'inside-out' signaling, reducing cell adhesion and enhancing migration.
- Cyclin D1 overexpression correlates with cancer metastasis.
Conclusions:
- Rho GTPase signaling pathways are integral to breast cancer malignancy.
- The 'inside-out' signaling function of cyclin D1 presents a novel therapeutic target for inhibiting breast cancer cell migration and metastasis.
More Related Videos
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a superfamily...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cell Polarization by Rho Proteins
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...